EXPD vs ITRM · P/E 26, rev $10.60B vs rev $390.0K
Expeditors International of Washington, Inc. (EXPD) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the EXPD and ITRM stock pages for the full models.
Not investment advice.